TrialThe oncologist2024

A novel risk classification model integrating CEA, ctDNA, and pTN stage for stage 3 colon cancer: a post hoc analysis of the IDEA-France trial.

Thomas Samaille et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.